Early invasive cervical adenocarcinoma

Summary

Early invasive cervical adenocarcinoma (MONDO:0004530) is a disease and 1 clinical trial. A subtype of cervical adenocarcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	early invasive cervical adenocarcinoma
Mondo ID	MONDO:0004530
DOID	DOID:8307
NCIT	C36096
UMLS	C1333369
MedGen	232144
GARD	0024051
Is cancer (heuristic)	no

Also known as: cervical microinvasive adenocarcinoma

Disease family

This is a subtype of cervical adenocarcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › cervical adenocarcinoma › early invasive cervical adenocarcinoma

Related subtypes (9): endocervical adenocarcinoma, uterine ligament adenocarcinoma, cervical mucinous adenocarcinoma, Wolffian duct adenocarcinoma, cervical serous adenocarcinoma, cervical endometrioid adenocarcinoma, cervical adenoid cystic carcinoma, cervical adenosquamous carcinoma, cervical clear cell adenocarcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02140021	Not specified	TERMINATED	Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer